SCHEMBL6285594

SCHEMBL6285594

COc1ccc(-c2cc3c([nH]2)CCCC3)cc1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.41
MEN1 O00255 2/20 0.40
MAPT P10636 2/20 0.40
KMT2A Q03164 2/20 0.40
TSHR P16473 2/20 0.40
HTT P42858 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 5/20 0.39
CYP3A4 P08684 2/20 0.39
PDGFRB P09619 2/20 0.38
THRB P10828 1/20 0.38
FGFR1 P11362 1/20 0.38
KDR P35968 1/20 0.38
PARP1 P09874 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TUBB4A P04350 2/20 0.35
TUBB P07437 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6285586 0.81 ACVR1 (0.40) MAPTKDM4EALDH1A1PDGFRBTHRB
SCHEMBL28535196 0.75 KDM4E (0.46) MEN1MAPTKMT2AKDM4EALDH1A1
SCHEMBL7096737 0.74 NPY5R (0.45) GAAHTTKDM4EALDH1A1CYP3A4
SCHEMBL6286952 0.72 NPY5R (0.39) GAAKDM4EALDH1A1CYP3A4PDGFRB
SCHEMBL7104266 0.72 PDGFRB (0.38) GAAMEN1MAPTKMT2ATSHR
SCHEMBL6863931 0.71 ALDH1A1 (0.67) GAAMEN1MAPTKMT2ATSHR
SCHEMBL31607677 0.71 ALDH1A1 (0.67) GAAMEN1MAPTKMT2ATSHR
SCHEMBL30839809 0.71 ALDH1A1 (0.67) GAAMEN1MAPTKMT2ATSHR
SCHEMBL6285038 0.70 KMT2A (0.49) GAAMEN1MAPTKMT2AKDM4E
SCHEMBL6286258 0.70 MAPT (0.46) GAAMEN1MAPTKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040014759-A1 6,5-Fused bicyclic heterocycles PICARD JOSEPH ARMAND (US) 2004-01-22 US claimed
EP-1294718-A2 6,5-FUSED BICYCLIC HETEROCYCLES WARNER-LAMBERT COMPANY LLC (US) 2003-03-26 EP claimed
WO-2001096336-A2 6,5-FUSED BICYCLIC HETEROCYCLES WARNER-LAMBERT COMPANY (US) 2001-12-20 WO claimed
US-6943174-B2 6,5-Fused bicyclic heterocycles WARNER-LAMBERT COMPANY (US) 2005-09-13 US disclosed
EP-1294718-A2 6,5-FUSED BICYCLIC HETEROCYCLES WARNER-LAMBERT COMPANY LLC (US) 2003-03-26 EP disclosed
WO-2001096336-A2 6,5-FUSED BICYCLIC HETEROCYCLES WARNER-LAMBERT COMPANY (US) 2001-12-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014759-A1 6,5-Fused bicyclic heterocycles ALOX15, ALOX5, ALOX15B GAA 2700/4885MEN1 3508/4885MAPT 4625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.